Rate My Professor Neveen Ahmed Abdelaziz

Abdelaziz's research specializations encompass antimicrobial resistance mechanisms, bacterial biofilm disruption, phage therapy, and discovery of novel antibacterial and antifungal agents from microbial sources. Key publications include 'Phenotype-genotype correlations among carbapenem-resistant Enterobacterales recovered from four Egyptian hospitals with the report of SPM carbapenemase' (Antimicrobial Resistance & Infection Control, 2022), 'In Silico Docking, Resistance Modulation and Biofilm Gene Expression in Multidrug-Resistant Acinetobacter baumannii via Cinnamic and Gallic Acids' (Antibiotics, 2022), 'In vitro, genomic characterization and pre-clinical evaluation of a new thermostable lytic Obolenskvirus phage formulated as a hydrogel against carbapenem-resistant Acinetobacter baumannii' (Scientific Reports, 2025), 'Genomic characterization and pre-clinical evaluation of a new carbapenem-resistant Klebsiella pneumoniae ST307 strain isolated from a COVID-19 patient in Egypt' (Applied Microbiology and Biotechnology, 2025), 'Nanosponge hydrogel of octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl) propanoate of Alcaligenes faecalis' (Applied Microbiology and Biotechnology, 2024), 'Lysinibacillus Isolate MK212927: A Natural Producer of Allylamine Antifungal 'Terbinafine'' (Molecules, 2021), and 'Oral Mucosal Stem Cells, Human Immature Dental Pulp Stem Cells and Hair Follicle Bulge Stem Cells as Adult Stem Cells Able to Correct Limbal Stem Cell Deficiency' (Current Stem Cell Research & Therapy, 2018). These contributions highlight her impact on addressing multidrug-resistant pathogens through innovative microbiological approaches.